Induction of muscle protein degradation by a tumour factor

British Journal of Cancer

Volumn 76, Issue 8, 1997, Pages 1035-1040

  Lorite, M J ^a   Cariuk, P ^a   Tisdale, M J ^a  

^a ASTON UNIVERSITY   (United Kingdom)

Author keywords

Cancer cachexia; Prostaglandin E2; Proteolysis inducing factor

Indexed keywords

AMINO ACID; GLUCOSE; ICOSAPENTAENOIC ACID; MONOCLONAL ANTIBODY; MUSCLE PROTEIN; PROSTAGLANDIN E2; TUMOR MARKER;

AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN ANTIBODY REACTION; ARTICLE; BODY WATER; BODY WEIGHT; CACHEXIA; CONTROLLED STUDY; FLUID INTAKE; FOOD INTAKE; GASTROCNEMIUS MUSCLE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; SOLEUS MUSCLE;

EID: 0030880483     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.504     Document Type: Article

References (33)

1. Beck SA and Tisdale MJ (1987) Production of lipolytic and proteolytic factors by a murine tumor-producing cachexia in the host. Cancer Res 47: 5919-5923
2. Beck SA and Tisdale MJ (1989) Nitrogen excretion in cancer cachexia and its modification by a high fat diet in mice. Cancer Res 49: 3800-3804
3. Beck SA, Smith KL and Tisdale MJ (1991) Anticachectic and antitumor effect of cicosapentaenoic acid and its effect on protein turnover. Cancer Res 51: 6089-6093
4. Brennan MF (1977) Uncomplicated starvation versus cancer cachexia. Cancer Res 37: 2359-2364
5. Clark CM and Goodlad GAJ (1971) Depletion of proteins of phasic and tonic muscles in tumour-hearing rats. Eur J Cancer 7: 3-9
6. Clarke EF, Lewis AH and Waterhouse (1978) Peripheral amino acid levels in patients with cancer. Cancer 42: 2909-2913
7. Cohn SH, Gartenhaus W and Sawitsky A (1998) Compartmental body composition of cancer patients with measurement of total body nitrogen, potassium and water. Metabolism 30: 222-229
8. Costa G (1963) Cachexia, the metabolic component of neoplastic diseases. Prog Exp Tumor Res 3: 321-369
9. De Wys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR, Cohen MH Douglass HD, Engston PF Ezindlie Z, Horton J, Johnson GJ, Moertel CG, Oken MM, Perla C, Rosenbaum C, Sinerstein MN, Skeel RT, Sponzo RW and Formey DC (1980) Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Med 69: 491-497
10. Flores EA, Bistrain BR, Pomposelli JJ, Dinarello CA, Blackburn GL and Istfan N (1989) Infusion of tumor necrosis factor/cachectin promotes muscle catabolism in the rat. A synergism with interleukin 1. J Clin Invest 83: 1614-1622
11. Garcia-Martinez C, Lopez-Soriano FJ and Argiles JM (1994) Interleukin-6 does not activate protein breakdown in rat skeletel muscle. Cancer Lett 76: 1-4
12. 2 production in rat skeletal muscle in fever is signaled by a macrophage product distinct from interleukin-1 or other known monokines. J Clin Invest 81: 1378-1383
13. 2 does not regulate total or myofibrillar protein breakdown in incubated skeletal muscle from normal or septic rats. Biochem J 270: 45-50
14. Hellerstein MA, Meydan SN, Meydan M, Wu K and Dinarello C (1989) Interleukin 1 induced anorexia in the rat. Influence of prostaglandins. J Clin Invest 84: 228-235
15. Lopes N, Black P, Ashford AJ and Pain VM (1989) Protein metabolism in the tumour-bearing mouse. Biochem J 264: 713-719
16. Lundholm K, Bylund AC, Holm J and Schersten T (1976) Skeletal muscle metabolism in patients with malignant tumour. Eur J Cancer 12: 465-471
17. Lundholm K, Edstrom S, Karlberg I, Ekman L and Schersten T (1980) Relationship of food intake, body composition and tumour growth to host metabolism in non-growing mice with sarcoma. Cancer Res 40: 2515-2522
18. McDevitt TM and Tisdale MJ (1992) Tumour-associated hypoglycaemia in a murine cachexia model. Br J Cancer 66: 815-820
19. Moley JF, Aamodt R, Rumble W, Kaye W and Norton JA (1987) Body cell mass in cancer bearing and anorexic patients. J Parent Ent Nutr 11: 219-222
20. Norton JA, Gorschboth CM and Wesley RA (1985) Fasting plasma amino acid levels in cancer patients. Cancer 56: 1181-1186
21. O'Keefe SJD, Ogden J, Ramjee G and Rund J (1990) Contribution of elevated protein turnover and anorexia to cachexia in patients with hepatocellular carcinoma. Cancer Res 50: 1226-1231
22. Palmer RM (1990) Prostaglandins and the control of muscle protein synthesis and degradation. Prostag Leukotr Essential Fatty Acids 39: 95-104
23. Palmer RM and Wahle KWJ (1987) Protein synthesis and degradation in isolated muscle. Biochem J 242: 615-618
24. Reeds P, Hay S, Glennie R, Mackie W and Garlick P (1985) The effect of indomethacin on the stimulation of protein synthesis by insulin in young post-absorptive rats. Biochem J 227: 255-261
25. 2α, influence rates of protein turnover in skeletal and cardiac muscle. J Biol Chem 257: 1632-1638
26. Rotman E, Brostrom MA and Brostrom CO (1992) Inhibition of protein synthesis in intact mammalian cells by arachidonic acid. Biochem J 282: 487-494
27. Smith KL and Tisdale MJ (1993a) Increased protein degradation and decreased protein synthesis in skeletal muscle during cancer cachexia. Br J Cancer 67: 680-685
28. Smith KL and Tisdale MJ (1993b) Mechanism of muscle protein catabolism in cancer cachexia. Br J Cancer 68: 314-318
29. Strelkov AB, Fields ALA and Baracos VE (1989) Effects of systemic inhibition of prostaglandin production on protein metabolism in tumour-bearing rats. Am J Physiol 257: C261-C269
30. Tessitore L, Costelli P and Baccino FM (1994) Pharmacological interference with tissue hypercatabolism in tumour-bearing rats. Biochem J 299: 71-78
31. Todorov P, Cariuk P, McDevitt T, Coles B, Fearon K and Tisdale M (1996a) Characterization of a cancer cachectic factor. Nature 379: 739-742
32. Todorov PT, McDevitt TM, Cariuk P, Coles B, Deacon M and Tisdale MJ (1996b) Induction of muscle protein degradation and weight loss by a tumor product. Cancer Res 56: 1256-1261
33. Waalkes TP and Udenfriend SA (1957) A fluorometric method for the estimation of tyrosine in plasma and tissues. J Lab Clin Med 50: 733-736